Vanguard Capital Management
ORGO icon

Vanguard Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Vanguard Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.06M Buy
2,905,919
+5,103
+0.2% +$12.5K ﹤0.01% 2985
2026
Q1 		$6.87M Buy
+2,900,816
New +$10M ﹤0.01% 2927

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management's ORGO Position: Q2 2026 in Review

Vanguard Capital Management increased its Organogenesis Holdings (ORGO) stake by 0.18% in Q2 2026, buying an estimated $12.5K and bringing the position to 2,905,919 shares worth $7.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2985.

Vanguard Capital Management first reported a position in ORGO in Q1 2026 and has held it in 2 quarters since. 133 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Vanguard Capital Management held 2,905,919 shares of Organogenesis Holdings worth $7.06M as of Q2 2026.
  • Vanguard Capital Management bought 5,103 Organogenesis Holdings shares in Q2 2026, an estimated $12.5K.
  • Organogenesis Holdings made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2985 holding.
  • Vanguard Capital Management first reported a position in Organogenesis Holdings in Q1 2026 and has held it in 2 quarters since.
  • 133 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.